Hypoxia reduces the output of matrix metalloproteinase-9 (MMP-9) in monocytes by inhibiting its secretion and elevating membranal association

Journal of Leukocyte Biology

Volumn 79, Issue 4, 2006, Pages 706-718

  Rahat, Michal A ^a   Marom, Barak ^a,b   Bitterman, Haim ^a,b   Weiss Cerem, Lea ^a,b   Kinarty, Amalia ^a   Lahat, Nitza ^a  

^a CARMEL MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Human; Inflammation; Macrophages

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIN; CYTOCHALASIN B; GELATINASE B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NOCODAZOLE; PD 98050; RHO GUANOSINE TRIPHOSPHATASE; SN 50; TUBULIN; TUMOR NECROSIS FACTOR ALPHA; CD44 PROTEIN, HUMAN; CYTOKINE; HERMES ANTIGEN;

ACTIN POLYMERIZATION; ARTICLE; CELL ADHESION; CELL HYPOXIA; CELL MEMBRANE; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; ENZYME RELEASE; HUMAN; HUMAN CELL; MICROTUBULE ASSEMBLY; MONOCYTE; PRIORITY JOURNAL; SECRETORY VESICLE; STEADY STATE; ZYMOGRAPHY; BINDING SITE; CELL LINE; CELL MOTION; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; ENZYMOLOGY; IMMUNOLOGY; SECRETION; SURFACE PROPERTY;

ANTIGENS, CD44; BINDING SITES; CELL HYPOXIA; CELL LINE; CELL MEMBRANE; CELL MOVEMENT; CYTOCHALASIN B; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MATRIX METALLOPROTEINASE 9; MONOCYTES; NOCODAZOLE; SURFACE PROPERTIES;

EID: 33746442968     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0605302     Document Type: Article

References (53)

1. Nathan, C. (2003) Oxygen and the inflammatory cell. Nature 422, 675-676.
2. Sica, A., Saccani, A., Mantovani, A. (2002) Tumor-associated macrophages: a molecular perspective. Int. Immunopharmacol. 2, 1045-1054.
3. Grimshaw, M. J., Blackwill, F. R. (2001) Inhibition of monocytes and macrophages chemotaxis by hypoxia and inflammation - a potential mechanism. Eur. J. Immunol. 31, 480-489.
4. Murdoch, C., Giannoudis, A., Lewis, C. E. (2004) Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104, 2224-2234.
5. Lewis, J. S., Lee, J. A., Underwood, J. C. E., Harris, A. L., Lewis, C. E. (1999) Macrophage responses to hypoxia: relevance to disease mechanisms. J. Leukoc. Biol. 66, 889-900.
6. Sellebjerg, F., Sorensen, T. L. (2003) Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system. Brain Res. Bull. 61, 347-355.
7. Seiki, M., Koshikawa, N., Yana, I. (2003) Role of pericellular proteolysis by membrane-type 1 matrix metalloproteinase in cancer invasion and angiogenesis. Cancer Metastasis Rev. 22, 129-143.
8. Nagase, H. (1997) Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378, 151-160.
9. Visse, R., Nagase, H. (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92, 827-839.
10. Mawrin, C., Brunn, A., Rocken, C., Schroder, J. M. (2003) Peripheral neuropathy in systemic lupus erythematosus: pathomorphological features and distribution pattern of matrix metalloproteinases. Acta Neuropathol. (Berl.) 105, 365-372.
11. Nygardas, P. T., Hinkkanen, A. E. (2002) Up-regulation of MMP-8 and MMP-9 activity in the Balb/c mouse spinal cord correlates with the severity of experimental autoimmune encephalomyelitis. Clin. Exp. Immunol. 128, 245-254.
12. Moon, S. K., Cha, B. Y., Kim, C. H. (2004) ERK1/2 mediates TNFα-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NFκB and AP-1: involvement of the ras dependent pathway. J. Cell. Physiol. 198, 417-427.
13. Ma, Z., Shah, R. C., Chang, M. J., Benveniste, E. N. (2004) Coordination of cell signaling, chromatin remodeling, histone modifications, and regulator recruitment in human matrix metalloproteinase 9 gene transcription. Mol. Cell. Biol. 24, 5496-5509.
14. Overall, C. M., Lopez-Otin, C. (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat. Rev. Cancer 2, 657-672.
15. Ogawa, K., Chen, F., Kuang, C., Chen, Y. (2004) Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-β is mediated by a NFκB site. Biochem. J. 381, 413-422.
16. Vincenti, M. P., Brinckerhoff, C. E. (2002) Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. 4, 157-164.
17. Van den Steen, P. E., Dubois, B., Nelissen, I., Rudd, P. M., Dwek, R. A., Opdenakker, G. (2002) Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 37, 375-536.
18. Lazure, C. (2002) The peptidase zymogen proregions: nature's way of preventing undesired activation and proteolysis. Curr. Pharm. Des. 8, 511-531.
19. Gardner, J., Ghorpade, A. (2003) Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system. J. Neurosci. Res. 74, 801-806.
20. Opdenakker, G., Van Den Steen, P. E., Dubois, B., Nelissen, I., Van Coillie, E., Masure, S., Proost, P., Van Damme, J. (2001) Gelatinase B functions as a regulator and effector in leukocyte biology. J. Leukoc. Biol. 69, 851-859.
21. Fridman, R., Toth, M., Chvyrkova, I., Meroueh, S. O., Mobashery, S. (2003) Cell surface association of matrix metalloproteinase 9 (gelatinase B). Cancer Metastasis Rev. 22, 153-166.
22. Kolev, K., Skopal, J., Simon, L., Csonka, E., Machovich, R., Nagy, Z. (2003) Matrix metalloproteinase-9 expression in post-hypoxic human brain capillary endothelial cells: H2O2 as a trigger and NFkB as a signal transducer. Thromb. Haemost. 90, 528-537.
23. Ben-Yosef, Y., Lahat, N., Shapiro, S., Bitterman, H., Miller, A. (2002) Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation. Circ. Res. 90, 784-791.
24. Canning, M. T., Postovit, L. M., Clarke, S. H., Graham, C. H. (2001) Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinase-1 expression by invasive cells. Exp. Cell Res. 267, 88-94.
25. Zhong, H., Simons, J. W. (1999) Direct comparison of GAPDH, β-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia. Biochem. Biophys. Res. Commun. 259, 523-526.
26. Gordillo, G. M., Sen, C. K. (2003) Revisiting the essential role of oxygen in wound healing. Am. J. Surg. 186, 259-263.
27. Chase, A. J., Bond, M., Crook, M. F., Newby, A. C. (2002) Role of nuclear factor-κB activation in metalloproteinase-1, -3, and -9 secretion in human macrophages in vitro and rabbit foam cells produced in vivo. Arterioscler. Thromb. Vasc. Biol. 22, 765-771.
28. Rosengart, M. R., Arbabi, S., Garcia, I., Maier, R. V. (2000) Interactions of calcium/calmodulin-dependent protein kinase (CaMK) and extracellular-regulated kinase (ERK) in monocyte adherence and TNFα production. Shock 13, 183-189.
29. Olson, M. W., Toth, M., Gervasi, D. C., Sado, Y., Ninomiya, Y., Fridman, R. (1998) High-affinity binding of latent matrix metalloproteinase-9 to the α(IV) chain of collagen IV. J. Biol. Chem. 273, 10672-10681.
30. Sultan, S., Gosling, M., Nagase, H., Powell, J. T. (2004) Shear stress-induced shedding of soluble intercellular adhesion molecule from saphenous vein endothelium. FEBS Lett. 564, 161-165.
31. Yu, Q., Stamenkovic, I. (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev. 14, 163-176.
32. Bourguignon, L. Y., Gunja-Smith, Z., Iida, N., Zhu, H. B., Young, L. J., Muller, W. J., Cardiff, R. D. (1998) CD44 v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J. Cell. Physiol. 176, 206-215.
33. Takahashi, C., Sheng, Z., Horan, T. P., Kitayama, H., Maki, M., Hitomi, K., Kitaura, Y., Takai, S., Sasahara, R. M., Horimoto, A., Ikawa, Y., Ratzkin, B. J., Arakawa, T., Noda, M. (1998) Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc. Natl. Acad. Sci. USA 95, 13221-13226.
34. Noda, M., Oh, J., Takahashi, R., Kondo, S., Kitayama, H., Takahashi, C. (2003) RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling. Cancer Metastasis Rev. 22, 167-175.
35. Rhee, J. S., Coussens, L. M. (2002) RECKing MMP function: implications for cancer development. Trends Cell Biol. 12, 209-211.
36. Hahn-Dantona, E., Ruiz, J. F., Bornstein, P., Strickland, D. K. (2001) The low density lipoprotein receptor-related protein modulates levels of matrix metalloproteinase 9 (MMP-9) by mediating its cellular catabolism. J. Biol. Chem. 276, 15498-15503.
37. Chintala, S. K., Kyritsis, A. P., Mohan, P. M., Mohanam, S., Sawaya, R., Gokaslan, Z., Yung, W. K., Steck, P., Uhm, J. H., Aggarwal, B. B., Rao, J. (1999) Altered actin cytoskeleton and inhibition of matrix metalloproteinase expression by vanadate and phenylarsine oxide, inhibitors of phosphotyrosine phosphatases: modulation of migration and invasion of human malignant glioma cells. Mol. Carcinog. 26, 274 -285.
38. Chintala, S. K., Sawaya, R., Aggarwal, B. B., Majumder, S., Giri, D. K., Kyritsis, A. P., Gokaslan, Z., Rao, J. (1998) Induction of matrix metalloproteinase-9 requires a polymerized actin cytoskeleton in human malignant glioma cells. J. Biol. Chem. 273, 13545-13551.
39. Tomasek, J. J., Halliday, N. L., Updike, D. L., Ahern-Moore, J. S., Vu, T. K., Liu, R. W., Howard, E. W. (1997) Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J. Biol. Chem. 272, 7482-7487.
40. Olson, M. W., Bernardo, M. M., Pietila, M., Gervasi, D. C., Toth, M., Kotra, L. P., Massova, I., Mobashery, S., Fridman, R. (2000) Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9. Differential rates for activation by stromelysin 1. J. Biol. Chem. 275, 2661-2668.
41. Toth, M., Gervasi, D. C., Fridman, R. (1997) Phorbol ester-induced cell surface association of matrix metalloproteinase-9 in human MCF10A breast epithelial cells. Cancer Res. 57, 3159-3167.
42. Alonso, D. F., Farina, H. G., Arregui, C., Aon, M. A., Gomez, D. E. (1999) Modulation of urokinase-type plasminogen activator and metalloproteinase activities in culture mouse mammary carcinoma cells: enhancement by pacitaxel and inhibition by nocodazole. Int. J. Cancer 83, 242-246.
43. Hattula, K., Furuhjelm, J., Arffman, A., Peranen, J. (2002) A Rab8-specific GDP/GTP exchange factor is involved in actin remodeling and polarized membrane transport. Mol. Biol. Cell 13, 3268-3280.
44. Wittmann, T., Bokoch, G. M., Waterman-Storer, C. M. (2003) Regulation of leading edge microtubule and actin dynamics downstream of Rac1. J. Cell Biol. 161, 845-851.
45. Yoon, S-O., Shin, S., Mercurio, A. M. (2005) Hypoxia stimulates carcinoma invasion by stabilizing microtubules and promoting the Rab11 trafficking of the α6β4 integrin. Cancer Res. 65, 2761-2769.
46. Honing, H., van der Berg, T. K., van der Pol, S. M., Dijkstra, C. D., van der Kammen, R. A., de Vries, H. E. (2004) RhoA activation promotes transendothelial migration of monocytes via ROCK. J. Leukoc. Biol. 75, 523-528.
47. Worthylake, R. A., Burridge, K. (2003) RhoA and ROCK promote migration by limiting membrane protrusions. J. Biol. Chem. 278, 13578-13584.
48. Turcotte, S., Desrosiers, R. R., Beliveau, R. (2004) Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma. Am. J. Physiol. Renal Physiol. 286, F338-F348.
49. Chellaiah, M. A., Biswas, R. S., Rittling, S. R., Denhardt, D. T., Hruska, K. A. (2003) Rho-dependent Rho kinase activation increases CD44 surface expression and bone resorption in osteoclasts. J. Biol. Chem. 278, 29086-29097.
50. Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S. K., Doni, A., Rapisarda, A., Bernasconi, S., Saccani, S., Nebuloni, M., Vago, L., Mantovani, A., Melillo, G., Sica, A. (2003) Regulation of the chemokine receptor CXCR4 by hypoxia. J. Exp. Med. 198, 1391-1402.
51. Daniliuc, S., Bitterman, H., Rahat, M. A., Kinarty, A., Rosenzweig, D., Lahat, N. (2003) Hypoxia inactivates iNOS in mouse macrophages by disrupting its interaction with α-actinin 4. J. Immunol. 171, 3225-3232.
52. Melillo, G., Taylor, L. S., Brooks, A., Cox, G. W., Varesio, L. (1996) Regulation of inducible nitric oxide synthase expression in IFNγ-treated murine macrophages cultured under hypoxic conditions. J. Immunol. 157, 2638-2644.
53. Lahat, N., Rahat, M. A., Ballan, M., Weiss-Cerem, L., Engelmayer, M., Bitterman, H. (2003) Hypoxia reduces CD80 expression on monocytes, but enhances their LPS-stimulated TNFα secretion. J. Leukoc. Biol. 74, 197-205.